Xcout Intel
ChemoMouthpiece, LLC
ChemoMouthpiece, LLC offers an FDA-cleared, prescription-only oral cryotherapy device designed to cool the oral cavity during and after chemotherapy. The reusable device is intended for adult cancer patients to reduce the incidence, severity, and associated pain of chemotherapy-induced oral mucositis.
Subscribe to see ChemoMouthpiece, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ChemoMouthpiece, LLC at a glance
ChemoMouthpiece, LLC is a medical device company headquartered in United States. It has raised at least $15.9M across the 3 funding rounds on record. Its most recent funding round raised $900,000 in November 2024. Xcout tracks 5 named people at ChemoMouthpiece, LLC, including David Yoskowitz (President and Manager).
ChemoMouthpiece, LLC leadership
- David YoskowitzPresident and Manager
- David YoskowitzFounder
- David YoskowitzExecutive Officer
- Jeffrey SchwabDirector
- Shlomo Dov LehrmanDirector
ChemoMouthpiece, LLC funding rounds
At least $15.9M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $900,000 | — | |
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $10M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
ChemoMouthpiece, LLC competitors
A few of ChemoMouthpiece, LLC's closest competitors — see the full list of competitors and alternatives →
Kubanda Cryotherapy provides minimally invasive cryotherapy treatments as an alternative to surgery for lumps, bumps, and cancers in pets. The company serves veterinarians and pet parents by offering a point-of-care solution designed to improve animal quality of life without the need for traditional surgical resections.
NebuPure Technologies, LLC offers a portable mesh nebulizer designed for quiet and effective respiratory therapy for adults and children. The device features fine mist delivery and includes both adult and child masks as well as a mouthpiece for versatile everyday use at home or while traveling.
CQ Medical is a global leader in developing patient radiotherapy positioning systems and cancer therapy solutions designed to advance human care.
SymPhysis Medical is a medical technology company that develops the rel eaze™ Drainage System, an intuitive device designed for at-home pleural effusion management. The product aims to provide patients suffering from chronic conditions like cancer with a less invasive and more independent method for symptom drainage.
Clyra Medical Technologies, Inc. develops advanced wound management and irrigation products utilizing patent-protected oxidative chemistry. The company serves patients and healthcare providers by offering safe, non-toxic treatments designed to combat microorganisms and aid in wound healing without harming healthy tissue.
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Get ChemoMouthpiece, LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ChemoMouthpiece, LLC in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access